NO861724L - Tetrapyrrol-holdige diagnostiske midler. - Google Patents

Tetrapyrrol-holdige diagnostiske midler.

Info

Publication number
NO861724L
NO861724L NO86861724A NO861724A NO861724L NO 861724 L NO861724 L NO 861724L NO 86861724 A NO86861724 A NO 86861724A NO 861724 A NO861724 A NO 861724A NO 861724 L NO861724 L NO 861724L
Authority
NO
Norway
Prior art keywords
tetrapyrrol
diagnostic agents
containing diagnostic
detection
treatment
Prior art date
Application number
NO86861724A
Other languages
English (en)
Other versions
NO173319C (no
NO173319B (no
Inventor
Jerry C Bommer
Bruce F Burnham
Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Petrochemicals Co Ltd filed Critical Nippon Petrochemicals Co Ltd
Publication of NO861724L publication Critical patent/NO861724L/no
Publication of NO173319B publication Critical patent/NO173319B/no
Publication of NO173319C publication Critical patent/NO173319C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO861724A 1985-04-30 1986-04-30 Anvendelse av et olefyrin for p}visning av tumorer NO173319C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72878685A 1985-04-30 1985-04-30

Publications (3)

Publication Number Publication Date
NO861724L true NO861724L (no) 1986-10-31
NO173319B NO173319B (no) 1993-08-23
NO173319C NO173319C (no) 1993-12-01

Family

ID=24928279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861724A NO173319C (no) 1985-04-30 1986-04-30 Anvendelse av et olefyrin for p}visning av tumorer

Country Status (8)

Country Link
EP (1) EP0210351B1 (no)
JP (1) JPH0764728B2 (no)
AT (1) ATE91625T1 (no)
AU (1) AU589957B2 (no)
CA (1) CA1291710C (no)
DE (1) DE3688721T2 (no)
DK (1) DK168690B1 (no)
NO (1) NO173319C (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
JPS63192718A (ja) * 1987-02-06 1988-08-10 Hamari Yakuhin Kogyo Kk 肝障害抑制剤
CA1341460C (en) * 1988-01-11 2004-10-19 The Medical College Of Ohio Production and use of porphyrin derivatives and of compositions containing such derivates
US4916711A (en) * 1988-09-29 1990-04-10 Boyer Joseph H Lasing compositions and methods for using the same
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US4997639A (en) * 1989-11-27 1991-03-05 Nippon Petrochemicals Company, Limited Method for detecting cholesterol deposited in bodies of mammals
US5446157A (en) * 1990-04-23 1995-08-29 Morgan; Lee R. Boron difluoride compounds useful in photodynamic therapy and production of laser light
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
HUT76327A (en) * 1994-05-13 1997-08-28 Monsanto Co Pharmaceutical compositions catalyzing decomposition of peroxy-nitrite
AU2002222104B2 (en) 2000-11-29 2007-06-28 Pci Biotech As Photochemical internalization for virus-mediated molecule delivery into the cyosol
AU2002220853B2 (en) 2000-11-29 2007-06-28 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
CN101977608A (zh) * 2009-04-29 2011-02-16 多异亚德韩国株式会社 含有二氢卟酚e6-叶酸共轭化合物和壳聚糖的用于癌症治疗的药物组合物
RU2537759C1 (ru) * 2013-07-12 2015-01-10 Евгений Валерьевич Жаров Способ фотодинамической терапии онкологических заболеваний
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids
RU2604388C2 (ru) * 2015-04-29 2016-12-10 Евгений Владимирович Давыдов Флуоресцентная диагностика злокачественного новообразования животного

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5819644B2 (ja) 1975-03-13 1983-04-19 ウェルファイド株式会社 スイチユウボウオザイ
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
JPS5587792A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Meso-tetra(p-carboxyphenyl)porphine derivative
JPS57185220A (en) * 1981-05-07 1982-11-15 Yakult Honsha Co Ltd Carcinostatic agent containing chlorophyll derivative as active component
JPS58981A (ja) * 1981-06-26 1983-01-06 Tama Seikagaku Kk 水溶性ポルフイリン誘導体
WO1983000811A1 (en) 1981-09-08 1983-03-17 Stancon, Alexei Photoradiation method and arrangement
DE3381616D1 (de) * 1982-09-27 1990-07-05 Photofrin Medical Inc Gereinigte hemaf 3381400inabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren.
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents

Also Published As

Publication number Publication date
AU5689186A (en) 1986-11-06
AU589957B2 (en) 1989-10-26
DE3688721D1 (de) 1993-08-26
DE3688721T2 (de) 1993-12-16
EP0210351A3 (en) 1990-09-05
NO173319C (no) 1993-12-01
DK168690B1 (da) 1994-05-24
ATE91625T1 (de) 1993-08-15
DK197286D0 (da) 1986-04-30
EP0210351B1 (en) 1993-07-21
EP0210351A2 (en) 1987-02-04
JPH0764728B2 (ja) 1995-07-12
CA1291710C (en) 1991-11-05
DK197286A (da) 1987-01-23
NO173319B (no) 1993-08-23
JPS625912A (ja) 1987-01-12

Similar Documents

Publication Publication Date Title
NO861724L (no) Tetrapyrrol-holdige diagnostiske midler.
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO864425L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
DE3750668D1 (de) 7-[3-(Aminomethyl)-3-alkyl-1-pyrrolidinyl]chinolin-3-carbonsäure-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
DK528086D0 (da) N-substituerede 3-piperidincarboxylsyrer eller n-substituerede 3-pyridincarboxylsyrer og derivater deraf
SE8505920D0 (sv) New protein and its use
NO164982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
IT1198238B (it) Composti ad attivita' antibiotica
HK175896A (en) Medicament for the treatment of cardiac insufficiency
FI893677A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-fluori-3,5-dihydroksikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
NO171108C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater
NO170930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-okso-3-kinolinkarboksylsyrer
ATE58521T1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
NO169716C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske beta-laktam-karboksylsyrer
ATE65396T1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
SE8701110D0 (sv) Terapeutisk indikation for kend substansgrupp
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
PT87077A (pt) Terc-butylamino-3-(phenyl-2:-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance
NO881256D0 (no) Fremgangsmaate for fremstilling av 5-hydroksydiprafenon og syreaddisjonssalter derav.
FI893001A (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1,2-bensisoxazol-3-yl- och 1,2-bensisotiazol -3-ylderivat.
NO169712C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksom 1-benzooksacykloalkyl-pyridinkarboksylsyre-forbindelse

Legal Events

Date Code Title Description
MK1K Patent expired